What's Happening?
Researchers from KTH Royal Institute of Technology and Karolinska Institutet in Sweden have identified rare DNA changes that may cause bicuspid aortic valve (BAV), the most common heart defect present at birth. The study, published in Nature Communications,
found nearly 30 times more potential genes linked to BAV than previously known. BAV is characterized by a valve with only two cusps instead of the usual three, leading to complications such as valve narrowing or aortic enlargement. The research focused on regulatory regions of the genome, which act as switches for important genes during early development. Using a technique called HiCap, the team mapped how DNA is arranged in cells and how regulatory regions connect to key developmental genes. They discovered that rare mutations in these regulatory parts of DNA likely play a major role in causing BAV.
Why It's Important?
This research significantly enhances the understanding of the genetic complexity of BAV, which affects many individuals who often require surgery later in life. By identifying the genetic underpinnings of BAV, the study opens up possibilities for improved genetic risk assessment and potential new treatments. The findings highlight the importance of regulatory DNA regions in congenital heart defects, suggesting that genetic mutations affecting these areas can have long-lasting impacts. This could lead to advancements in prenatal screening and early interventions, potentially reducing the incidence and severity of BAV-related complications.
